Tales from the Trenches™ with Sheila Mikhail, Co-founder and CEO of AskBio
The MATTER Health Podcast
<p>Sheila Mikhail founded Asklepios BioPharmaceutical (AskBio) in 2001 and set out on a mission to bring life-changing drugs to patients in desperate need. Started during a time when gene therapy was not thought of as a realistic therapeutic approach, AskBio went without a round of funding for more than 15 years.<br/><br/>With the belief that their therapeutics could change the world, Sheila, her co-founder Jude Samulski and their team persevered. Over the course of 20 years, Sheila transformed AskBio into a gene therapy pioneer with an established global operation of more than 350 employees. In 2020, AskBio was acquired by Bayer AG for $4 billion.<br/><br/>Sheila was recently named Ernst & Young’s 2021 Entrepreneur of the Year National Overall Award Winner. Among her many notable accomplishments, Sheila’s commitment to diversity and inclusion stands out — today, 41 percent of AskBio’s leadership positions are held by women, which is significantly higher than other biotech companies.<br/><br/>On December 13, Sheila sat down with MATTER CEO Steven Collens to discuss her entrepreneurial journey, her perseverance and vision for AskBio and lessons she has learned along the way.</p><p><br/>For more information, visit <a href='https://matter.health/'>matter.health</a> and follow us on social:</p> <p><b>LinkedIn </b><a href='https://www.linkedin.com/company/matter-chicago'>@MATTER</a><br/><b>Twitter</b> <a href='https://twitter.com/MATTERhealth'>@MATTERhealth</a><br/><b>Instagram </b><a href='https://www.instagram.com/matterhealth/'>@matterhealth</a></p>